![]() |
|
|
HA Wieland, KD Willim, M Entzeroth, W Wienen, K Rudolf, W Eberlein, W Engel and HN Doods
Preclinical Research Department, Dr. Karl Thomae GmbH, Biberach, Germany.
In the present study, the subtype specificity and species selectivity of the nonpeptide BIBP 3226, as well as its in vitro antagonism of neuropeptide Y (NPY)-mediated second messengers have been investigated. Radiolabeled NPY is potently displaced by BIBP 3226 [(R)-N2- (diphenylacetyl)-N-[(4-hydroxyphenylmethyl]-D- arginine amide] on human Y1 receptor expressing Chinese hamster ovary-K1 cells (Ki = 0.47 +/- 0.07 nM). SK-N-MC human neuroblastoma cells (Ki = 5.1 +/- 0.5 nM) and the rat parietal cortex membranes (Ki = 6.8 +/- 0.7 nM). The interaction of BIBP 3226 with the Y1 receptor is stereoselective, because the (S)-enantiomer of the (R)-configured BIBP 3226 displays almost no affinity (Ki > 10,000 nM). In contrast, concentrations up to 10 microM BIBP 3226 do not displace [125I]NPY from the human Y2 receptor (neuroblastoma cell line SMS-KAN), the rabbit Y2 receptor (kidney) and the rat Y2 receptor (hippocampus). Functional antagonism could be shown for the human Y1 receptor: 0.1 microM BIBP 3226 antagonizes the NPY induced Ca++ mobilization (pKb = 7.5 +/- 0.17) as well as the NPY-mediated inhibition of cyclic AMP synthesis (pKb = 8.2 +/- 0.24) in SK-N-MC cells. In contrast, none of the formerly described putative antagonists PYX-2, [D-Trp32]NPY and benextramine could be characterized as high affinity Y1 receptor antagonists. The 18 amino acid NPY analog EXBP 68 Ile-Glu-Pro-Orn-Tyr-Arg-Leu-Arg-Tyr-NH2, cyclic (2,4'), (2',4')-diamide] displayed Y1-selective affinity with in vitro antagonistic properties (Ki = 0.33 +/- 0.04 nM and pKb = 8.4 +/- 0.07) in SK-N-MC cells. Therefore, BIBP 3226 is the first potent and subtype- selective nonpeptide Y1 receptor antagonist.
This article has been cited by other articles:
![]() |
E. L. Dimitrov, M. R. DeJoseph, M. S. Brownfield, and J. H. Urban Involvement of Neuropeptide Y Y1 Receptors in the Regulation of Neuroendocrine Corticotropin-Releasing Hormone Neuronal Activity Endocrinology, August 1, 2007; 148(8): 3666 - 3673. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Misra, K. S. Murthy, H. Zhou, and J. R. Grider Coexpression of Y1, Y2, and Y4 Receptors in Smooth Muscle Coupled to Distinct Signaling Pathways J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1154 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Floriano, N. Vaidehi, and W. A. Goddard III Making Sense of Olfaction through Predictions of the 3-D Structure and Function of Olfactory Receptors Chem Senses, May 1, 2004; 29(4): 269 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Grider and L. E. Langdon Physiological role of neuropeptide Y in the regulation of the ascending phase of the peristaltic reflex Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1139 - G1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Yannielli and M. E. Harrington The Neuropeptide Y Y5 Receptor Mediates the Blockade of "Photic-Like" NMDA-Induced Phase Shifts in the Golden Hamster J. Neurosci., July 15, 2001; 21(14): 5367 - 5373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xu, J. H. Urban, J. W. Hill, and J. E. Levine Regulation of Hypothalamic Neuropeptide Y Y1 Receptor Gene Expression during the Estrous Cycle: Role of Progesterone Receptors Endocrinology, September 1, 2000; 141(9): 3319 - 3327. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hoyo, J. C. McGrath, and E. Vila Evidence for Y1-Receptor-Mediated Facilitatory, Modulatory Cotransmission by NPY in the Rat Anococcygeus Muscle J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 38 - 44. [Abstract] [Full Text] |
||||
![]() |
D. Renshaw, L. M. Thomson, M. Carroll, S. Kapas, and J. P. Hinson Actions of Neuropeptide Y on the Rat Adrenal Cortex Endocrinology, January 1, 2000; 141(1): 169 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Iyengar, D. L. Li, and R. M. A. Simmons Characterization of Neuropeptide Y-Induced Feeding in Mice: Do Y1-Y6 Receptor Subtypes Mediate Feeding? J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1031 - 1040. [Abstract] [Full Text] |
||||
![]() |
L. Sun and R. J. Miller Multiple Neuropeptide Y Receptors Regulate K+ and Ca2+ Channels in Acutely Isolated Neurons From the Rat Arcuate Nucleus J Neurophysiol, March 1, 1999; 81(3): 1391 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-O. Carlsson, A. Andersson, and L. Jansson Influence of age, hyperglycemia, leptin, and NPY on islet blood flow in obese-hyperglycemic mice Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E594 - E601. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dumont, A. Fournier, and R. Quirion Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain J. Neurosci., August 1, 1998; 18(15): 5565 - 5574. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Parker, M. S. Parker, T. Sweatman, and W. R. Crowley Characterization of G Protein and Phospholipase C-Coupled Agonist Binding to the Y1 Neuropeptide Y Receptor in Rat Brain: Sensitivity to G Protein Activators and Inhibitors and to Inhibitors of Phospholipase C J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 382 - 391. [Abstract] [Full Text] |
||||
![]() |
M. C. Michel, A. Beck-Sickinger, H. Cox, H. N. Doods, H. Herzog, D. Larhammar, R. Quirion, T. Schwartz, and T. Westfall XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors Pharmacol. Rev., March 1, 1998; 50(1): 143 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, C.-L. Yang, X. Chen, L. Naes, B. F. Cox, and T. Westfall Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H290 - H294. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rhim, G. A. Kinney, P. J. Emmerson, and R. J. Miller Regulation of Neurotransmission in the Arcuate Nucleus of the Rat by Different Neuropeptide Y Receptors J. Neurosci., May 1, 1997; 17(9): 2980 - 2989. [Abstract] [Full Text] [PDF] |
||||